Literature DB >> 21993608

[Increased transparency in thin-slice computed tomography of lung parenchyma].

J Ley-Zaporozhan1.   

Abstract

Areas with reduced density are a common finding with thin-slice computed tomography (CT) examinations of lung parenchyma. Diffuse and localized patterns can be differentiated. The most frequent cause for a diffuse decrease in density is pulmonary emphysema which can be classified into centrilobular, panlobular and paraseptal emphysema based on the distinct anatomical features. A mosaic pattern (due to mosaic perfusion or air trapping) is also characterized by a diffuse decrease in density. Focal cystic changes can be differentiated from emphysematous changes and mosaic patterns which do not reveal wall structures. Langerhans cell histiocytosis and lymphangioleiomyomatosis are the most frequent cystic diseases of the lung parenchyma. Based on the geometry and anatomical distribution of the cysts a differentiation is mostly possible. Rare diseases leading to a reduced lung density include the Birt-Hogg-Dubé syndrome, lymphoid interstitial pneumonia as well as congenital diseases or diseases which are acquired during early childhood, such as cystic adenomatoid malformation or Swyer-James syndrome.

Entities:  

Mesh:

Year:  2011        PMID: 21993608     DOI: 10.1007/s00117-011-2238-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  36 in total

1.  Bronchial atresia: three-dimensional CT bronchography using volume rendering technique.

Authors:  S Kawamoto; M Yuasa; S Tsukuda; A Heshiki
Journal:  Radiat Med       Date:  2001 Mar-Apr

Review 2.  Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2010 May-Jun       Impact factor: 2.409

Review 3.  Cysts, cavities, and honeycombing in multisystem disorders: differential diagnosis and findings on thin-section CT.

Authors:  L A Grant; J Babar; N Griffin
Journal:  Clin Radiol       Date:  2009-01-09       Impact factor: 2.350

4.  Expanding upon the unilateral hyperlucent hemithorax in children.

Authors:  Jonathan R Dillman; Ramon Sanchez; Maria F Ladino-Torres; Sai G Yarram; Peter J Strouse; Javier Lucaya
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

5.  Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.

Authors:  D N Franz; A Brody; C Meyer; J Leonard; G Chuck; S Dabora; G Sethuraman; T V Colby; D J Kwiatkowski; F X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

Review 6.  Rare lung diseases I--Lymphangioleiomyomatosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2006-10       Impact factor: 2.409

7.  Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex.

Authors:  M E A P M Adriaensen; C M Schaefer-Prokop; D A C Duyndam; B A Zonnenberg; M Prokop
Journal:  Clin Radiol       Date:  2011-04-02       Impact factor: 2.350

8.  Lymphangioleiomyomatosis: abdominopelvic CT and US findings.

Authors:  N A Avila; J A Kelly; S C Chu; A J Dwyer; J Moss
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

Review 9.  Birt-Hogg-Dubé syndrome: diagnosis and management.

Authors:  Fred H Menko; Maurice A M van Steensel; Sophie Giraud; Lennart Friis-Hansen; Stéphane Richard; Silvana Ungari; Magnus Nordenskjöld; Thomas Vo Hansen; John Solly; Eamonn R Maher
Journal:  Lancet Oncol       Date:  2009-12       Impact factor: 41.316

Review 10.  BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.

Authors:  J R Toro; M-H Wei; G M Glenn; M Weinreich; O Toure; C Vocke; M Turner; P Choyke; M J Merino; P A Pinto; S M Steinberg; L S Schmidt; W M Linehan
Journal:  J Med Genet       Date:  2008-01-30       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.